Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,449 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,432
Recruiting: 781
Ph III recruiting: 109
Growth YoY: +20.5%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 1,501–1,550 of 1,978 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03701451	Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma	unknown	Phase 1 / Phase 2	30	Wei JiangOTHER	1	Oct 10, 2018	clinicaltrials
NCT03096184	A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers	unknown	Phase 2	38	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER	1	Oct 9, 2018	clinicaltrials